A new drug stalls the growth of tumors in women with advanced breast cancer. Testing was stopped after noting the drug’s effectiveness, so that all the women could be given the chance to benefit:
A novel experimental drug (Tykerb) delayed the growth of tumors nearly twice as long as standard chemotherapy did in patients who had stopped responding to Herceptin, doctors reported Saturday. (Boston.com via AP Medical writer )